These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30088101)

  • 21. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
    Zaka M; Abbasi BH; Durdagi S
    J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual screening based on pharmacophore model followed by docking simulation studies in search of potential inhibitors for p38 map kinase.
    Shahlaei M; Doosti E
    Biomed Pharmacother; 2016 May; 80():352-372. PubMed ID: 27133076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
    Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
    Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents.
    Cele FN; Ramesh M; Soliman ME
    Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.
    Kaur M; Singh PK; Singh M; Bahadur R; Silakari O
    Mol Divers; 2018 Feb; 22(1):95-112. PubMed ID: 29138965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
    Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
    Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors.
    Suebsuwong C; Pinkas DM; Ray SS; Bufton JC; Dai B; Bullock AN; Degterev A; Cuny GD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):577-583. PubMed ID: 29409752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors.
    Kumar V; Parate S; Danishuddin ; Zeb A; Singh P; Lee G; Jung TS; Lee KW; Ha MW
    Front Cell Infect Microbiol; 2022; 12():909111. PubMed ID: 35846777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.
    Singh N; Tiwari S; Srivastava KK; Siddiqi MI
    J Chem Inf Model; 2015 Jun; 55(6):1120-9. PubMed ID: 25965448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.
    Bavi R; Kumar R; Choi L; Woo Lee K
    PLoS One; 2016; 11(1):e0147190. PubMed ID: 26784025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
    Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
    Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations.
    Ashiru MA; Ogunyemi SO; Temionu OR; Ajibare AC; Cicero-Mfon NC; Ihekuna OA; Jagun MO; Abdulmumin L; Adisa QK; Asibor YE; Okorie CJ; Lawal MO; Babalola MO; Abdulrasaq IT; Salau LB; Olatunji IO; Bankole MA; Daud AB; Adeyemi AO
    J Mol Model; 2023 Apr; 29(5):128. PubMed ID: 37016200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.
    Tigno-Aranjuez JT; Benderitter P; Rombouts F; Deroose F; Bai X; Mattioli B; Cominelli F; Pizarro TT; Hoflack J; Abbott DW
    J Biol Chem; 2014 Oct; 289(43):29651-64. PubMed ID: 25213858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atom Based 3D-QSAR, Molecular Docking and Density Functional Theory Approaches to Identify Novel JNK-1 Inhibitor.
    Shylaja R; Kavitha R; Meganathan C
    Comb Chem High Throughput Screen; 2016; 19(9):771-797. PubMed ID: 27585829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening of B-Raf kinase inhibitors: A combination of pharmacophore modelling, molecular docking, 3D-QSAR model and binding free energy calculation studies.
    Zhang W; Qiu KX; Yu F; Xie XG; Zhang SQ; Chen YJ; Xie HD
    Comput Biol Chem; 2017 Oct; 70():186-190. PubMed ID: 28892749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening.
    Jasuja H; Chadha N; Singh PK; Kaur M; Bahia MS; Silakari O
    Comput Biol Chem; 2018 Oct; 76():109-117. PubMed ID: 29990790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches.
    Santos KLBD; Cruz JN; Silva LB; Ramos RS; Neto MFA; Lobato CC; Ota SSB; Leite FHA; Borges RS; Silva CHTPD; Campos JM; Santos CBR
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.